24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Weight Loss
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:39
Full list of Israeli high-tech layoffs in 2026
21:36
Remitly cuts 110 jobs in Israel and closes R&D hub three years after $80 million Rewire acquisition
16:41
Rigas: "Energean needs more gas to compete, and to prevent a monopoly"
16:31
“When you raise walls around data, employees go around them”
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race
2
Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”
3
Cyera employees to sell tens of millions in shares at $9 billion valuation
4
Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion
5
Israeli startup raises $6.2 million to turn social media video into intelligence
More news
Weight Loss
4 stories about Weight Loss
Epitomee surges 200% in two days on FDA approval for weight loss pill
16.09.24
|
Adiel Eithan Mustaki
Investors are hopeful, but the company must now face an uphill battle in a crowded market.
Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement
04.12.23
|
Adiel Eithan Mustaki
The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level
Weight loss pill success sparks stock surge at Epitomee Medical
04.09.23
|
Adiel Eithan Mustaki
The company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway
Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns
16.02.20
|
Lilach Baumer
On Thursday, the manufacturer of Belviq weight loss drug, Eisai, announced it was withdrawing the drug from the U.S. market after a five-year trial found it increased risk of cancer by 0.6%